Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Short Interest Up 8.1% in November

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 14,700 shares, an increase of 8.1% from the October 31st total of 13,600 shares. Based on an average daily trading volume, of 17,900 shares, the days-to-cover ratio is currently 0.8 days. Approximately 0.5% of the shares of the stock are short sold.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Cryo-Cell International stock. Geode Capital Management LLC raised its position in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) by 68.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 39,860 shares of the company’s stock after acquiring an additional 16,203 shares during the quarter. Geode Capital Management LLC owned approximately 0.49% of Cryo-Cell International worth $254,000 at the end of the most recent quarter. 10.44% of the stock is currently owned by hedge funds and other institutional investors.

Cryo-Cell International Stock Performance

Shares of NYSEAMERICAN:CCEL traded up $0.03 during mid-day trading on Tuesday, reaching $8.57. 4,848 shares of the company’s stock were exchanged, compared to its average volume of 24,421. The firm has a market cap of $69.07 million, a PE ratio of 15.81 and a beta of 0.49. Cryo-Cell International has a twelve month low of $4.47 and a twelve month high of $9.50.

Cryo-Cell International (NYSEAMERICAN:CCEL) last released its earnings results on Tuesday, October 15th. The company reported $0.13 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.11. The business had revenue of $8.07 million during the quarter. Cryo-Cell International had a negative net margin of 28.03% and a negative return on equity of 42.06%.

Cryo-Cell International Dividend Announcement

The firm also recently disclosed a — dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were paid a $0.25 dividend. The ex-dividend date was Friday, November 15th. Cryo-Cell International’s dividend payout ratio (DPR) is presently -94.34%.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.